190 related articles for article (PubMed ID: 1387996)
1. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
[No Abstract] [Full Text] [Related]
2. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
3. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
Gertz MA; Brown ML; Hauser MF; Kyle RA
Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic cardiac amyloidosis in an American family.
Ruder MA; Alpert MA; Sanfelippo JF; Dix JD; Whiting RB
South Med J; 1984 Jul; 77(7):831-3. PubMed ID: 6330908
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography.
Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams D; Desgrez A; Blondeau M
Am J Cardiol; 1993 Oct; 72(11):854-7. PubMed ID: 8213531
[No Abstract] [Full Text] [Related]
7. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
[TBL] [Abstract][Full Text] [Related]
8. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
[TBL] [Abstract][Full Text] [Related]
10. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams A; Desgrez A; Blondeau M
Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1009-15. PubMed ID: 8291935
[TBL] [Abstract][Full Text] [Related]
11. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
12. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis.
Falk RH; Lee VW; Rubinow A; Skinner M; Cohen AS
Am J Cardiol; 1984 Nov; 54(8):1150-1. PubMed ID: 6093493
[No Abstract] [Full Text] [Related]
13. [Heart involvement in patients with periodic disease and amyloidosis].
Vinogradova OM; Kochubeĭ LN; Golyzhnikov VA; Tomas NIu; Eventov AZ; Pisareva NA
Ter Arkh; 1992; 64(9):81-6. PubMed ID: 1481162
[No Abstract] [Full Text] [Related]
14. [Current methods of examination in the diagnosis of sarcoidosis of the heart].
Moiseev SV; Kornev BM; Eventov AZ; Pisareva NA; Shatkovskiĭ NP
Kardiologiia; 1988 Jul; 28(7):41-4. PubMed ID: 2850392
[TBL] [Abstract][Full Text] [Related]
15. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
17. A non-invasive approach to the diagnosis of amyloid cardiomyopathy in elderly patients.
Ptacin M; Bamrah V; Sebastian J; Duthie E
Mil Med; 1986 Feb; 151(2):104-7. PubMed ID: 3008031
[No Abstract] [Full Text] [Related]
18. [Echography and scintigraphy using technetium 99m pyrophosphate in the diagnosis of cardiac amyloidosis].
Guy JM; Lamaud M; Segura C; Berthaud T; Duranton B; Verneyre H
Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):215-8. PubMed ID: 2544133
[TBL] [Abstract][Full Text] [Related]
19. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
Hongo M; Hirayama J; Fujii T; Yamada H; Okubo S; Kusama S; Ikeda S
Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
[No Abstract] [Full Text] [Related]
[Next] [New Search]